Feixia Wang

1.6k total citations · 1 hit paper
42 papers, 1.2k citations indexed

About

Feixia Wang is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Feixia Wang has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 20 papers in Hepatology and 10 papers in Molecular Biology. Recurrent topics in Feixia Wang's work include Liver Disease Diagnosis and Treatment (22 papers), Liver physiology and pathology (12 papers) and Liver Disease and Transplantation (5 papers). Feixia Wang is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Liver physiology and pathology (12 papers) and Liver Disease and Transplantation (5 papers). Feixia Wang collaborates with scholars based in China, United States and Hong Kong. Feixia Wang's co-authors include Shizhong Zheng, Jiangjuan Shao, Zili Zhang, Feng Zhang, Yan Jia, Mengmeng Li, Shanzhong Tan, Anping Chen, Anping Chen and Siwei Xia and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Free Radical Biology and Medicine.

In The Last Decade

Feixia Wang

40 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an LDH-A/HIF-1α transcriptional complex

2023 75 citations Feixia Wang, Desong Kong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Feixia Wang China	20	554	397	278	269	185	42	1.2k
Wenhui Mo China	17	651 1.2×	337 0.8×	226 0.8×	414 1.5×	111 0.6×	43	1.3k
Shanzhong Tan China	19	738 1.3×	431 1.1×	278 1.0×	423 1.6×	435 2.4×	40	1.4k
Jiannan Qiu China	20	694 1.3×	404 1.0×	241 0.9×	360 1.3×	100 0.5×	47	1.3k
Claudia Paternostro Italy	17	475 0.9×	525 1.3×	459 1.7×	289 1.1×	123 0.7×	23	1.3k
Xiaodong Ge United States	17	425 0.8×	631 1.6×	432 1.6×	150 0.6×	100 0.5×	40	1.5k
Desong Kong China	24	796 1.4×	582 1.5×	464 1.7×	417 1.6×	392 2.1×	51	1.8k
Cheng Ma China	17	512 0.9×	320 0.8×	187 0.7×	142 0.5×	58 0.3×	25	1.1k
Chang Yeob Han South Korea	21	611 1.1×	414 1.0×	160 0.6×	153 0.6×	81 0.4×	35	1.2k
Seonghwan Hwang South Korea	23	595 1.1×	878 2.2×	321 1.2×	326 1.2×	59 0.3×	51	1.7k
Taichiro Nishikawa Japan	24	543 1.0×	714 1.8×	395 1.4×	211 0.8×	75 0.4×	46	1.6k

Countries citing papers authored by Feixia Wang

Since Specialization

Citations

This map shows the geographic impact of Feixia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feixia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feixia Wang more than expected).

Fields of papers citing papers by Feixia Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feixia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feixia Wang. The network helps show where Feixia Wang may publish in the future.

Co-authorship network of co-authors of Feixia Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Feixia Wang. A scholar is included among the top collaborators of Feixia Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feixia Wang. Feixia Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Weidong, Meihui Wang, Siwei Xia, et al.. (2025). Induction of UBQLN1‐mediated PGC1α stability by isoliensinine overcame hypoxia‐induced resistance in liver cancer cells. BioFactors. 51(2). e70008–e70008. 1 indexed citations

Wang, Shuqi, Li Tang, Yang Li, et al.. (2025). Isoliensinine from Plumula Nelumbinis Attenuates Hepatic Fibrosis in Metabolic Associated Fatty Liver Disease through Regulating Lipid Droplet Metabolism. Journal of Future Foods.

Xu, Xuefen, Yujia Li, Sumin Sun, et al.. (2024). Inhibition of TFAM-Mediated Mitophagy by Oroxylin A Restored Sorafenib Sensitivity Under Hypoxia Conditions in HepG2 Cells. Pharmaceuticals. 17(12). 1727–1727. 1 indexed citations

Ni, Fei-Da, Feixia Wang, Jing Sun, et al.. (2024). Proteome-wide Mendelian randomization and functional studies uncover therapeutic targets for polycystic ovarian syndrome. The American Journal of Human Genetics. 111(12). 2799–2813. 2 indexed citations

Ye, Xiaohang, Yifeng Lin, Yanyun Ying, et al.. (2024). Human Amniotic Epithelial Stem Cells Alleviate Autoimmune Premature Ovarian Insufficiency in Mice by Targeting Granulosa Cells via AKT/ERK Pathways. Stem Cell Reviews and Reports. 20(6). 1618–1635. 5 indexed citations

Tian, Haoyuan, Shuqi Wang, Feng Zhang, et al.. (2024). Oxidative stress induces ferroptosis in tendon stem cells by regulating mitophagy through cGAS-STING pathway. International Immunopharmacology. 138. 112652–112652. 13 indexed citations

Chen, Xiaomei, Feixia Wang, Siwei Xia, et al.. (2023). Yi-Qi-Jian-Pi formula ameliorates immune function in acute-on-chronic liver failure by upregulating autophagy and mitochondrial biogenesis in CD8+ T lymphocytes. Journal of Ethnopharmacology. 308. 116276–116276. 5 indexed citations

Chen, Li, Siwei Xia, Feixia Wang, et al.. (2023). m6A methylation-induced NR1D1 ablation disrupts the HSC circadian clock and promotes hepatic fibrosis. Pharmacological Research. 189. 106704–106704. 18 indexed citations

Wang, Feixia, Zhanghao Li, Li Chen, et al.. (2022). Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1α/NF-κB feedback pathway to inhibit liver fibrosis. Acta Pharmaceutica Sinica B. 12(9). 3618–3638. 43 indexed citations

10.

Wang, Feixia, Baoyu Liang, Chun Jin, et al.. (2021). Yi-Qi-Jian-Pi Formula Suppresses RIPK1/RIPK3-Complex-Dependent Necroptosis of Hepatocytes Through ROS Signaling and Attenuates Liver Injury in Vivo and in Vitro. Frontiers in Pharmacology. 12. 658811–658811. 11 indexed citations

11.

Jia, Yan, Huanhuan Jin, Liyuan Gao, et al.. (2020). A novel lncRNA PLK4 up‐regulated by talazoparib represses hepatocellular carcinoma progression by promoting YAP‐mediated cell senescence. Journal of Cellular and Molecular Medicine. 24(9). 5304–5316. 18 indexed citations

12.

Li, Mengmeng, Jiangjuan Shao, Zijian Guo, et al.. (2020). Novel mitochondrion‐targeting copper(II) complex induces HK2 malfunction and inhibits glycolysis via Drp1‐mediating mitophagy in HCC. Journal of Cellular and Molecular Medicine. 24(5). 3091–3107. 41 indexed citations

13.

Zhang, Feng, Feixia Wang, Baoyu Liang, et al.. (2020). Liver regeneration in traditional Chinese medicine: advances and challenges. SHILAP Revista de lepidopterología. 8. 1–1. 3 indexed citations

14.

Zhang, Feng, Feixia Wang, Jianlin He, et al.. (2020). Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β‐catenin signalling via interaction with Gli1. British Journal of Pharmacology. 178(11). 2246–2265. 21 indexed citations

15.

Kai, Jun, Yang Xiang, Zhimin Wang, et al.. (2020). Oroxylin a promotes PGC-1α/Mfn2 signaling to attenuate hepatocyte pyroptosis via blocking mitochondrial ROS in alcoholic liver disease. Free Radical Biology and Medicine. 153. 89–102. 72 indexed citations

16.

Li, Zhanghao, Feixia Wang, Baoyu Liang, et al.. (2020). Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication. Signal Transduction and Targeted Therapy. 5(1). 280–280. 84 indexed citations

17.

Wang, Feixia, Yan Jia, Mengmeng Li, et al.. (2019). Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells. Cell Communication and Signaling. 17(1). 11–11. 44 indexed citations

18.

Wang, Feixia, et al.. (2019). LncRNA ZEB2-AS1 contributes to the tumorigenesis of gastric cancer via activating the Wnt/β-catenin pathway. Molecular and Cellular Biochemistry. 456(1-2). 73–83. 44 indexed citations

19.

Jia, Yan, Feixia Wang, Qin Guo, et al.. (2018). Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells. Redox Biology. 19. 375–387. 124 indexed citations

20.

Zhang, Feng, Shuai Lü, Jianlin He, et al.. (2017). Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α. Theranostics. 8(3). 610–626. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact